Afuco™ Anti-Human PCSK9 ADCC Therapeutic Antibody (ALD306), ADCC Enhanced
Anti-PCSK9 ADCC Enhanced Antibody (ALD306) is an ADCC enhanced antibody produced by our Afuco™ platform. The humanized mAb recognizes Proprotein convertase subtilisin/kexin type 9 (PCSK9). It can be used to treat cardiovascular dyslipidemia.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-733CL |
Pricing | Inquiry |
Host | Humanized |
Target | PCSK9 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |